KWMG
King Wealth Management Group Portfolio holdings
AUM
$737M
1-Year Est. Return
18.5%
1 Year Est. Return
+18.5%
AUM
$660M
AUM Growth
-$25.8M
(-3.8%)
Holding
164
Top Buys
| 1 | +$2.47M | |
| 2 | +$2.02M | |
| 3 | +$1.38M | |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.1M |
| 5 |
Hologic
HOLX
|
+$1.06M |
Top Sells
| 1 | +$1.65M | |
| 2 | +$1.02M | |
| 3 | +$960K | |
| 4 |
Stevanato
STVN
|
+$763K |
| 5 |
Eli Lilly
LLY
|
+$621K |
Sector Composition
| 1 | Technology | 16.86% |
| 2 | Financials | 9.27% |
| 3 | Healthcare | 8.42% |
| 4 | Consumer Staples | 5.18% |
| 5 | Consumer Discretionary | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AWF
151
AllianceBernstein Global High Income Fund
AWF
$935M
| $204K | 0.03% |
19,000
+4,000
|
|
||
152
WD-40
WDFC
$2.63B
| $203K | 0.03% |
831
-29
|
|
||
|
ETB
153
Eaton Vance Tax-Managed Buy-Write Income Fund
ETB
$438M
| $184K | 0.03% |
13,463
-1,472
|
|
||
154
KeyCorp
KEY
$18.6B
| $164K | 0.02% |
10,277
+16
|
|
||
155
Viatris
VTRS
$11.9B
| $113K | 0.02% |
+12,946
|
|
||
156
Heron Therapeutics
HRTX
$236M
| $59K | 0.01% |
26,799
|
|
||
157
MindMed
MNMD
$1.04B
| $59K | 0.01% |
10,000
|
|
||
158
Aldeyra Therapeutics
ALDX
$316M
| – | – |
-13,500
|
|
||
159
Ametek
AME
$42.8B
| – | – |
-1,365
|
|
||
160
Bank of America
BAC
$376B
| – | – |
-4,706
|
|
||
161
iShares US Healthcare Providers ETF
IHF
$829M
| – | – |
-20,000
|
|
||
162
Lazard
LAZ
$4.59B
| – | – |
-4,500
|
|
||
163
Novo Nordisk
NVO
$242B
| – | – |
-2,379
|
|
||
|
164
Stevanato
STVN
$6.67B
| – | – |
-35,000
|
|